Illumina Inc (ILU.DE)

Healthcare | Medical Diagnostics Research
Latest reporting period: 2026-03-29

Latest Quarter

2026-03-29

Revenue

$1.1B

Net Income

$134M

Operating Margin

21.3%

Free Cash Flow

$931M

Debt / Assets

59.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Illumina Inc (ILU.DE).
Income Statement (Quarterly) 2026-03-29 2025-03-30 2024-12-31 2024-12-29
Revenue 1,091,000,000 1,041,000,000 1,104,000,000 1,104,000,000
Cost of Revenue 347,000,000 358,000,000 376,000,000 376,000,000
Gross Profit 744,000,000 683,000,000 728,000,000 728,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 272,000,000 267,000,000 279,000,000 279,000,000
Operating Expenses 512,000,000 519,000,000 553,000,000 553,000,000
Operating Income 232,000,000 164,000,000 175,000,000 175,000,000
Interest Expense 0 25,000,000 25,000,000 25,000,000
Income Before Tax 157,000,000 182,000,000 187,000,000 188,000,000
Income Tax Expense 23,000,000 51,000,000 0 1,000,000
Net Income 134,000,000 131,000,000 187,000,000 187,000,000
Per Share
EPS 0.88 0.83 1.18 1.18
EPS Diluted 0.00 0.00 0.00 0.00